Menu Search
Equities

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

JIL:BER

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Actions
  • Price (EUR)0.0727
  • Today's Change0.004 / 5.06%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 13 2021 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.

  • Revenue in HKD (TTM)912.95m
  • Net income in HKD186.77m
  • Incorporated1996
  • Employees678.00
  • Location
    Jilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
  • Phone+86 4 358218333
  • Fax+86 4 358210005
  • Websitehttp://www.jlchanglong.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.